Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns Raymond A. TettehBarbara A. YankeyAlexander N. O. Dodoo Review Article Open access 28 January 2017 Pages: 273 - 283
Digitalis Use and the Risk of Breast Cancer: A Systematic Review and Meta-Analysis Chen ZhangShao-Hua XiePian Liu Systematic Review 28 January 2017 Pages: 285 - 292
Identification of Substandard Medicines via Disproportionality Analysis of Individual Case Safety Reports Zahra Anita TrippeBruno BrendaniDavid Lewis short communication 28 January 2017 Pages: 293 - 303
Antibiotic-Induced Liver Injury in Paediatric Outpatients: A Case-Control Study in Primary Care Databases Carmen FerrajoloKatia M. C. VerhammeMiriam C. J. M. Sturkenboom Original Research Article Open access 26 December 2016 Pages: 305 - 315
Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts Carrie E. PierceKhaled BouriNabarun Dasgupta Original Research Article Open access 02 January 2017 Pages: 317 - 331
Effectiveness of Risk Evaluation and Mitigation Strategies (REMS) for Lenalidomide and Thalidomide: Patient Comprehension and Knowledge Retention Nancy A. BrandenburgRobert BwireJerome B. Zeldis Original Research Article Open access 10 January 2017 Pages: 333 - 341
Signal Detection Based on Time to Onset Algorithm in Spontaneous Reporting System of China Tianyi ZhangXiaofei YeJia He Original Research Article 10 January 2017 Pages: 343 - 350
Diverging Conclusions from the Same Meta-Analysis in Drug Safety: Source of Data (Primary Versus Secondary) Takes a Toll Guillermo Prada-RamallalBahi TakkoucheAdolfo Figueiras Original Research Article 22 December 2016 Pages: 351 - 358
Comment on: “Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France” Alain Braillon Letter to the Editor 10 February 2017 Pages: 359 - 360
Authors’ Reply to Alain Braillon’s Comment on “Proactive regional pharmacovigilance system versus national spontaneous reporting for collecting safety data on concerning off-label prescribing practices: An example with baclofen and alcohol dependence in France’’ Marine AuffretJulien LabreucheBenjamin Rolland Letter to the Editor 10 February 2017 Pages: 361 - 362